277 related articles for article (PubMed ID: 27124246)
1. Nanostructured Lipid Carriers (NLC) as Vehicles for Topical Administration of Sesamol: In Vitro Percutaneous Absorption Study and Evaluation of Antioxidant Activity.
Puglia C; Lauro MR; Offerta A; Crascì L; Micicchè L; Panico AM; Bonina F; Puglisi G
Planta Med; 2017 Mar; 83(5):398-404. PubMed ID: 27124246
[TBL] [Abstract][Full Text] [Related]
2. Application of nanostructured lipid carriers: the prolonged protective effects for sesamol in in vitro and in vivo models of ischemic stroke via activation of PI3K signalling pathway.
Hassanzadeh P; Atyabi F; Dinarvand R; Dehpour AR; Azhdarzadeh M; Dinarvand M
Daru; 2017 Dec; 25(1):25. PubMed ID: 29262855
[TBL] [Abstract][Full Text] [Related]
3. Sesamol-loaded solid lipid nanoparticles for treatment of skin cancer.
Geetha T; Kapila M; Prakash O; Deol PK; Kakkar V; Kaur IP
J Drug Target; 2015 Feb; 23(2):159-69. PubMed ID: 25268273
[TBL] [Abstract][Full Text] [Related]
4. Nanostructured lipid dispersions for topical administration of crocin, a potent antioxidant from saffron (Crocus sativus L.).
Esposito E; Drechsler M; Mariani P; Panico AM; Cardile V; Crascì L; Carducci F; Graziano ACE; Cortesi R; Puglia C
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():669-677. PubMed ID: 27987758
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical characterization of lycopene-loaded nanostructured lipid carrier formulations for topical administration.
Okonogi S; Riangjanapatee P
Int J Pharm; 2015 Jan; 478(2):726-35. PubMed ID: 25479097
[TBL] [Abstract][Full Text] [Related]
6. Lipid nanoparticles as carrier for octyl-methoxycinnamate: in vitro percutaneous absorption and photostability studies.
Puglia C; Bonina F; Rizza L; Blasi P; Schoubben A; Perrotta R; Tarico MS; Damiani E
J Pharm Sci; 2012 Jan; 101(1):301-11. PubMed ID: 21905033
[TBL] [Abstract][Full Text] [Related]
7. Nanostructured lipid carriers as semisolid topical delivery formulations for diflucortolone valerate.
Abdel-Salam FS; Mahmoud AA; Ammar HO; Elkheshen SA
J Liposome Res; 2017 Mar; 27(1):41-55. PubMed ID: 26956098
[TBL] [Abstract][Full Text] [Related]
8. Ubidecarenone-Loaded Nanostructured Lipid Carrier (UB-NLC): Percutaneous Penetration and Protective Effects Against Hydrogen Peroxide-Induced Oxidative Stress on HaCaT Cells.
Wang J; Wang H; Xia Q
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29941831
[TBL] [Abstract][Full Text] [Related]
9. Sesamol, a major lignan in sesame seeds (Sesamum indicum): Anti-cancer properties and mechanisms of action.
Majdalawieh AF; Mansour ZR
Eur J Pharmacol; 2019 Jul; 855():75-89. PubMed ID: 31063773
[TBL] [Abstract][Full Text] [Related]
10. Study of the Interactions Occurring During the Encapsulation of Sesamol within Casein Micelles Reformed from Sodium Caseinate Solutions.
Santos Basurto MA; Cardador Martínez A; Castaño Tostado E; Bah M; Reynoso Camacho R; Amaya Llano SL
J Food Sci; 2018 Sep; 83(9):2295-2304. PubMed ID: 30085358
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of sesamol on plasma and tissue lipids in isoproterenol-induced cardiotoxicity in Wistar rats.
Vennila L; Pugalendi KV
Arch Pharm Res; 2012 Aug; 35(8):1465-70. PubMed ID: 22941490
[TBL] [Abstract][Full Text] [Related]
12. Formulation of tocopherol nanocarriers and in vitro delivery into human skin.
Abla MJ; Banga AK
Int J Cosmet Sci; 2014 Jun; 36(3):239-46. PubMed ID: 24697812
[TBL] [Abstract][Full Text] [Related]
13. Preparations and antioxidant activities of sesamol and it's derivatives.
Zhou S; Zou H; Huang G; Chen G
Bioorg Med Chem Lett; 2021 Jan; 31():127716. PubMed ID: 33249134
[TBL] [Abstract][Full Text] [Related]
14. Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery.
Cirri M; Bragagni M; Mennini N; Mura P
Eur J Pharm Biopharm; 2012 Jan; 80(1):46-53. PubMed ID: 21839833
[TBL] [Abstract][Full Text] [Related]
15. Design and characterization of Nanostructured lipid carriers (NLC) and Nanostructured lipid carrier-based hydrogels containing Passiflora edulis seeds oil.
Krambeck K; Silva V; Silva R; Fernandes C; Cagide F; Borges F; Santos D; Otero-Espinar F; Lobo JMS; Amaral MH
Int J Pharm; 2021 May; 600():120444. PubMed ID: 33713760
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of indomethacin percutaneous absorption from nanostructured lipid carriers (NLC): in vitro and in vivo studies.
Ricci M; Puglia C; Bonina F; Di Giovanni C; Giovagnoli S; Rossi C
J Pharm Sci; 2005 May; 94(5):1149-59. PubMed ID: 15793804
[TBL] [Abstract][Full Text] [Related]
17. Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin.
Liu Y; Wang L; Zhao Y; He M; Zhang X; Niu M; Feng N
Int J Pharm; 2014 Dec; 476(1-2):169-77. PubMed ID: 25280882
[TBL] [Abstract][Full Text] [Related]
18. Free radical reactions and antioxidant activities of sesamol: pulse radiolytic and biochemical studies.
Joshi R; Kumar MS; Satyamoorthy K; Unnikrisnan MK; Mukherjee T
J Agric Food Chem; 2005 Apr; 53(7):2696-703. PubMed ID: 15796613
[TBL] [Abstract][Full Text] [Related]
19. Development, characterization, and in vitro and in vivo evaluation of benzocaine- and lidocaine-loaded nanostructrured lipid carriers.
Puglia C; Sarpietro MG; Bonina F; Castelli F; Zammataro M; Chiechio S
J Pharm Sci; 2011 May; 100(5):1892-9. PubMed ID: 21374621
[TBL] [Abstract][Full Text] [Related]
20. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy.
Lombardi Borgia S; Regehly M; Sivaramakrishnan R; Mehnert W; Korting HC; Danker K; Röder B; Kramer KD; Schäfer-Korting M
J Control Release; 2005 Dec; 110(1):151-63. PubMed ID: 16297487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
